title: Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.
authors.affiliation: ADHD Outpatient Clinic, Child and Adolescent Psychiatric Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil. lrohde@terra.com.br
authors.forename: L A
authors.initials: LA
authors.lastname: Rohde
authors.forename: T
authors.initials: T
authors.lastname: Roman
authors.forename: M H
authors.initials: MH
authors.lastname: Hutz
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D008774:Methylphenidate / Q000627:therapeutic use; D009419:Nerve Tissue Proteins; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends*; D029701:Saccharomyces cerevisiae Proteins
chemical_list: C060858:DAT1 protein, S cerevisiae; D004268:DNA-Binding Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D029701:Saccharomyces cerevisiae Proteins; D008774:Methylphenidate